Aptevo Therapeutics Inc.APVONASDAQ
Loading
Year-over-year SG&A expense growth
Percentile
P27
Within normal range
vs 3Y Ago
-2.5x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | -13.14% |
| 2023 | -15.15% |
| 2022 | -5.61% |
| 2021 | 5.35% |
| 2020 | -0.09% |
| 2019 | -50.36% |
| 2018 | -18.63% |
| 2017 | -10.58% |
| 2016 | -10.17% |
| 2015 | 25.56% |